Valeria Gutowski - 26 Feb 2025 Form 4 Insider Report for Enfusion, Inc.

Role
Chief Accounting Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 Feb 2025
Net transactions value
$0
Form type
4
Filing time
28 Feb 2025, 16:06:42 UTC
Previous filing
10 Jan 2025
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +13,228 +38% $0.000000 48,031 26 Feb 2025 Direct F1
transaction ENFN Class A Common Stock Award $0 +2,125 +4.4% $0.000000 50,156 26 Feb 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 4,410, 4,409 and 4,409 on each of February 26, 2026, 2027 and 2028.
F2 Consists of fully vested shares issued under the Plan.